HCG

HCG (human chorionic gonadotropin) is a heterodimeric glycoprotein research compound composed of a common α-subunit and a hormone-specific β-subunit, used as a gonadotropin-receptor research peptide in laboratory models of LH/CG-receptor signaling. The native glycoprotein is sourced from urinary preparations or recombinant expression systems and is supplied as an investigational laboratory peptide for use in receptor pharmacology, ligand-binding research, and reproductive-axis investigation in research models.

Research interest in HCG focuses on its role as a model ligand for the luteinizing hormone / chorionic gonadotropin receptor (LHCGR), a class A G-protein-coupled receptor expressed across reproductive-axis tissues in research models. Because hCG and LH share the same receptor but display distinct intracellular signaling profiles, hCG is widely used as a reference compound for studying LH/CG-receptor signaling research, glycoprotein hormone structure-function relationships, and gonadotropin-pathway research in laboratory models (Cole, 2010, Reproductive Biology and Endocrinology; Casarini et al., 2018, Endocrine Reviews).

In laboratory research studies, hCG is used to investigate cyclic AMP / PKA-linked signaling, receptor-binding kinetics, steroid-pathway research in reproductive-axis cell models, and the influence of glycosylation state on receptor activation efficiency. Comparative research with LH and recombinant glycoform variants supports investigations of glycoprotein hormone biochemistry, ligand-receptor specificity, and downstream signaling-bias research in research models.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

Human chorionic gonadotropin is a heterodimeric glycoprotein hormone research compound originally characterized as a placental glycoprotein produced during early gestation in research models. Structurally it consists of a 92-residue α-subunit (shared with LH, FSH, and TSH) and a 145-residue β-subunit that confers hormone identity. The two subunits are non-covalently associated and decorated with multiple N- and O-linked carbohydrate side chains that contribute to the overall mass of approximately 37 kDa.

Historically, hCG preparations were obtained from biological sources such as urine of pregnant individuals, while recombinant expression in mammalian cell lines has enabled more standardized material for mechanistic research, assay development, and structure-function studies. The carbohydrate composition of hCG, including sialic acid content and glycoform diversity, has long been a research focus because glycosylation strongly influences receptor activation efficiency, plasma residency in laboratory species, and signaling output even when receptor-binding affinity is largely preserved.

This positioning at the intersection of glycoprotein hormone biochemistry, LH/CG-receptor signaling research, and reproductive-axis investigation has made hCG a widely used reference compound in receptor pharmacology research models. Comparative studies of hCG, LH, and engineered glycoform variants support laboratory research on gonadotropin-pathway research, ligand-receptor specificity, and signaling-bias research at the LHCGR.

1. LHCGR Engagement

HCG binds the luteinizing hormone / chorionic gonadotropin receptor (LHCGR), a class A G-protein-coupled receptor expressed across reproductive-axis tissues in research models. Receptor engagement stabilizes an active conformation that couples primarily to Gαs and modulates intracellular cyclic AMP, the canonical second messenger downstream of LHCGR in gonadotropin-receptor signaling research.

2. Cyclic AMP / PKA Signaling

Upon receptor activation, hCG modulates adenylyl cyclase and downstream protein kinase A signaling in research models. These cascades are studied in laboratory research as regulators of gene expression in reproductive-axis cell models, including transcription of genes involved in steroid-pathway research markers and reproductive-tissue cellular differentiation responses.

3. Glycosylation and Signaling Output

A major focus of LH/CG-receptor signaling research is how carbohydrate residues on hCG influence receptor activation efficiency and downstream signaling output. Comparative research with recombinant glycoform variants has shown that altering glycosylation can reduce signaling output even when receptor binding remains relatively preserved, highlighting glycan importance for signal transduction in research models.

4. Comparative Signaling versus LH

Because hCG and LH engage the same LHCGR but display distinct intracellular signaling profiles, hCG is widely used as a reference ligand for studying signaling-bias research at gonadotropin receptors. Laboratory research has characterized differences in cyclic AMP accumulation, β-arrestin recruitment, and receptor internalization kinetics between hCG and LH in research models (Casarini et al., 2018, Endocrine Reviews).

Research Applications

Conclusion

HCG is a heterodimeric glycoprotein hormone research compound widely used as a reference ligand in LH/CG-receptor signaling research and gonadotropin-pathway research models. By combining a well-characterized α/β heterodimer architecture with extensively studied glycosylation profiles, hCG supports laboratory research on glycoprotein hormone biochemistry, LHCGR receptor pharmacology, and reproductive-axis investigation in research models.

Research Use Disclaimer

This product is intended for research and laboratory use only. It is designed exclusively for in vitro research purposes. All information provided is for educational and research reference only. This product is not intended for human or animal use. It is not a drug, food, or cosmetic and must not be marketed, labeled, or used as such. Use and handling are restricted to trained and qualified professionals.